Related Experiment Videos

Idiopathic macrocytic anaemia in the aged: molecular and cytogenetic findings

P Anttila1, J Ihalainen, A Salo

  • 1Department of Internal Medicine, Helsinki City Hospital, Finland.

Insights

Elderly patients with unexplained large red blood cells (macrocytosis) often show molecular and cellular abnormalities. These findings suggest early stem cell disorders in patients not meeting myelodysplastic syndrome criteria.

Area of Science:

  • Hematology
  • Molecular Biology
  • Geriatrics

Background:

  • Macrocytosis in the elderly frequently stems from impaired hematopoietic stem cell differentiation.
  • Idiopathic macrocytic anemia and myelodysplastic syndromes (MDS) in older adults warrant investigation into underlying molecular and cellular changes.

Purpose of the Study:

  • To screen elderly patients with idiopathic macrocytic anemia or MDS for specific molecular and cell biological alterations.
  • To identify potential early indicators of stem cell disorders in elderly patients presenting with macrocytosis.

Main Methods:

  • Analysis of DNA methylation at the calcitonin A gene 5'-area.
  • Detection of NRAS point mutations at codons 12 and 13.
  • In vitro colony formation assays for peripheral blood progenitor cells.
  • Cytogenetic analysis of bone marrow cells.

Main Results:

  • Hypermethylation of the calcitonin A gene 5'-area was observed in 7 out of 15 patients.
  • Abnormalities in in vitro erythroid progenitor cell culture were found in 7 out of 15 patients.
  • Chromosomal aberrations and NRAS mutations were rare findings (3/12 and 0/15, respectively).
  • Eight of nine macrocytic patients without FAB-defined MDS showed at least one abnormality.

Conclusions:

  • A significant proportion of elderly patients with idiopathic macrocytosis exhibit molecular or cellular abnormalities.
  • These alterations may indicate early stages of stem cell disorders, particularly in patients not meeting full MDS criteria.
  • Further investigation into these markers could aid in early diagnosis and management of hematological stem cell disorders in the elderly.

Related Concept Videos